Rhythm Pharmaceuticals Announces Commercial Launch Of IMCIVREE(R) (setmelanotide) In Japan For Patients With Acquired Hypothalamic Obesity >RYTM

Dow Jones2026/10/13 23:30

By:Dow Jones

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Can AAVE Price Reach $200 as V4 Deposits Top $300 Million?

Coinpedia•2026/10/13 23:12

BRIEF-Hub Cyber Security Appoints Richard Paolone And Joseph Tung To Its Board Of Directors

Reuters•2026/10/13 21:03

World’s top copper mine in final bid to avert strike as prices rally

Mining.com•2026/10/13 21:00

SSR to buy Roxmore for $464M, boosts value of Nevada gold mine

Mining.com•2026/10/13 21:00